DIN 02462877 — ERELZI 25 MG
ERELZI is a solution of Etanercept marketed by SANDOZ CANADA INCORPORATED. The full Etanercept monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02462877
- Brand name
- ERELZI
- Active ingredient
- Etanercept
- Strength
- 25 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Biological response modifier (tumor necrosis factor inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Etanercept products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02455323 | BRENZYS | 50 MG | SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02455331 | BRENZYS | 50 MG | SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02274728 | ENBREL | 50 MG | SOLUTION | IMMUNEX CORPORATION | MARKETED |
| 02462850 | ERELZI | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02462869 | ERELZI | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02530295 | RYMTI | 50 MG | SOLUTION | LUPIN PHARMA CANADA LIMITED | MARKETED |
| 02530309 | RYMTI | 50 MG | SOLUTION | LUPIN PHARMA CANADA LIMITED | MARKETED |